1/17
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
To understand it at a 15-year-old level
think of your digestive tract as having a built-in alarm system. The moment food hits your stomach and intestines, your gut sends out a chemical text message (a hormone called GLP-1) to your pancreas. This message says: "Hey, food is coming down the pipe! Start warming up the insulin!" The remaining drugs either mimic this text message, stop it from being deleted, or act like the natural sidekick to insulin. Here is your full, detailed breakdown.
GLP-1 Receptor Agonists (The "Megaphones")
These are the blockbuster weight-loss and diabetes drugs you hear about in the news all the time (like Ozempic). They are synthetic copies of the gut's natural GLP-1 hormone, but engineered to last much longer and act much stronger.
The Drugs: Suffix "-tide" (Exenatide, Liraglutide, Dulaglutide, Semaglutide).
Administration: Mostly subcutaneous (SubQ) injections, though oral Semaglutide now exists.
GLP-1 Receptor Agonists: MOA
They bind to GLP-1 receptors and do four amazing things:
Increase Insulin: But only when glucose is present (meaning very low risk of hypoglycemia on their own!).
Decrease Glucagon: Stops the liver from dumping extra sugar into the blood.
Slow Gastric Emptying: Keeps food in the stomach longer, preventing post-meal sugar spikes.
Brain Satiety: They tell the brain, "You are full, stop eating."
GLP-1 Receptor Agonists: High-Yield Board Pearls & Toxicities
Massive Weight Loss
Gastrointestinal Distress
The Black Box Warning (CRITICAL EXAM PEARL): They carry a severe warning for causing Thyroid C-Cell Tumors (Medullary Thyroid Carcinoma) in rats. They are strictly contraindicated in patients with a personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).
Acute Pancreatitis
Massive Weight Loss
Because they slow down the stomach and tell the brain you are full, patients lose a significant amount of weight.
Gastrointestinal Distress
Nausea, vomiting, and diarrhea are extremely common because the stomach is physically emptying slower.
Acute Pancreatitis
They can cause severe inflammation of the pancreas (look for a case study patient presenting with severe, radiating abdominal pain).
DPP-4 Inhibitors (The "Message Savers")
If GLP-1 is a text message, DPP-4 is the enzyme (the "auto-delete" feature) that destroys the message in your bloodstream within 2 minutes.
The Drugs: Suffix "-gliptin" (Sitagliptin, Saxagliptin, Linagliptin).
Administration: Oral tablets.
DPP-4 Inhibitors: MOA
They inhibit the DPP-4 enzyme. By blocking the enzyme that destroys GLP-1, they allow the body's own natural GLP-1 to stick around longer and do its job.
The Contrast: Because they only protect the natural GLP-1 you already make, their effects are much milder than the GLP-1 agonist injections. They are weight neutral (no massive weight loss).
DPP-4 Inhibitors: High-Yield Board Pearls & Toxicities
Extremely Well-Tolerated
Severe Joint Pain
The Linagliptin Exception (CRITICAL EXAM PEARL)
Extremely Well-Tolerated
These are very safe, easy-to-take oral drugs with no GI nightmare side effects.
Severe Joint Pain
A rare but highly testable side effect is severe, disabling arthralgia (joint pain) that resolves when the drug is stopped.
The Linagliptin Exception (CRITICAL EXAM PEARL)
Almost all diabetes drugs require dose adjustments if the patient's kidneys are failing. Linagliptin is the ONLY one that does not require renal dose adjustment. It is excreted primarily through the feces/bile, making it the safest choice for a patient with severe Chronic Kidney Disease (CKD). (Memory Hack: Linagliptin is Liberated from the kidneys).
Amylin Analogs (The Insulin Sidekick)
When a healthy pancreas secretes insulin, it also co-secretes another hormone called Amylin. Amylin acts like insulin's little helper to slow down gastric emptying and suppress glucagon.
The Drug: Pramlintide.
Administration: Subcutaneous injection (given immediately before major meals).
Mechanism of Action (MOA): It is a synthetic copy of human amylin.
Amylin Analogs: High-Yield Board Pearls & Toxicities
The Type 1 Exception (CRITICAL EXAM PEARL): Almost every non-insulin drug we have talked about is strictly for Type 2 Diabetes. Pramlintide is uniquely approved for BOTH Type 1 and Type 2 Diabetes.
The Hypoglycemia Trap: Because Type 1 diabetics take it with their mealtime insulin, the risk of severe hypoglycemia is massive. The golden rule is: When starting Pramlintide, you must decrease the patient's mealtime short-acting insulin dose by 50%.
GLP-1 Agonists
Suffix / Drug: "-tide" (Exenatide)
Effect on Weight: Weight Loss
Route: Injection
Ultimate Board Pearl: Black Box: Medullary Thyroid Cancer. Promotes massive weight loss.
DPP-4 Inhibitors
Suffix / Drug: "-gliptin" (Sitagliptin)
Effect on Weight: Weight Neutral
Route: Oral
Ultimate Board Pearl: Linagliptin requires NO renal dose adjustment.
Amylin Analogs
Suffix / Drug: Pramlintide
Effect on Weight: Weight Loss
Route: Injection
Ultimate Board Pearl: Approved for Type 1 and Type 2 DM. Must reduce mealtime insulin by half.